EVE Health Group Limited (ASX:EVE)
Australia · Delayed Price · Currency is AUD 0.0150
0.00 (0.00%)
Sep 4, 2026, 10:27 AM AEST
EVE Health Group Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 1.15 | 1.73 | 2.13 | 2.33 | 2.01 | |
Revenue Growth | -33.53% | -18.70% | -8.45% | 16.00% | -28.27% |
Cost of Revenue | 0.63 | 0.91 | 1.26 | 1.5 | 1.26 |
Gross Profit | 0.53 | 0.82 | 0.88 | 0.83 | 0.75 |
Selling, General & Admin | 1.05 | 1.95 | 2.16 | 2.66 | 4.16 |
Other Operating Expenses | 1.38 | 0.33 | 0.29 | 0.52 | 0.73 |
Operating Expenses | 2.43 | 2.28 | 2.45 | 3.18 | 4.89 |
Operating Income | -1.9 | -1.45 | -1.58 | -2.35 | -4.15 |
Interest Expense | - | -0 | -0 | - | -0.02 |
Interest & Investment Income | - | - | - | 0 | - |
Earnings From Equity Investments | - | - | - | -0.25 | -0.34 |
Other Non Operating Income (Expenses) | 0.01 | 0 | 0 | 0.07 | 0.27 |
EBT Excluding Unusual Items | -1.89 | -1.45 | -1.58 | -2.53 | -4.25 |
Gain (Loss) on Sale of Investments | - | - | 0.03 | 0.22 | - |
Gain (Loss) on Sale of Assets | - | - | -0 | 0.05 | -0.03 |
Asset Writedown | - | - | - | -0.09 | -0.84 |
Pretax Income | -1.89 | -1.45 | -1.55 | -2.35 | -5.12 |
Earnings From Continuing Operations | -1.89 | -1.45 | -1.55 | -2.35 | -5.12 |
Earnings From Discontinued Operations | - | -0.13 | -0.35 | -1.69 | -0.25 |
Net Income | -1.89 | -1.58 | -1.9 | -4.04 | -5.37 |
Net Income to Common | -1.89 | -1.58 | -1.9 | -4.04 | -5.37 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 291 | 137 | 132 | 130 | 100 |
Shares Outstanding (Diluted) | 291 | 137 | 132 | 130 | 100 |
Shares Change | 111.60% | 4.25% | 1.07% | 30.10% | 4.94% |
EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.03 | -0.05 |
EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.03 | -0.05 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -1.74 | -1.62 | -1.11 | -1.65 | -3.8 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.04 |
Gross Margin | 45.75% | 47.50% | 41.10% | 35.52% | 37.09% |
Operating Margin | -164.81% | -83.82% | -73.91% | -100.84% | -206.53% |
Profit Margin | -163.97% | -91.08% | -89.09% | -173.51% | -267.37% |
Free Cash Flow Margin | -151.20% | -93.13% | -51.88% | -70.83% | -189.02% |
EBITDA | -1.77 | -1.45 | -1.57 | -2.16 | -3.89 |
EBITDA Margin | -153.28% | -83.81% | -73.77% | -92.51% | -193.77% |
D&A For EBITDA | 0.13 | 0 | 0 | 0.19 | 0.26 |
EBIT | -1.9 | -1.45 | -1.58 | -2.35 | -4.15 |
EBIT Margin | -164.81% | -83.82% | -73.91% | -100.84% | -206.53% |